Personalized Medicine Biomarkers Market (By Application: Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring; By Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Frequently Asked Questions

The global personalized medicine biomarkers market size was reached at USD 16.51 billion in 2023 and it is projected to hit around USD 71.34 billion by 2033.

The global personalized medicine biomarkers market is growing at a compound annual growth rate (CAGR) of 15.76% from 2024 to 2033.

The North America region has accounted for the largest personalized medicine biomarkers market share in 2023.

The leading companies operating in the personalized medicine biomarkers market are Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Agilent Technologies, Inc., Genome Medical, Inc., Coriell Life Sciences., Thermo Fisher Scientific Inc., NeoGenomics Laboratories, FOUNDATION MEDICINE, INC., Illumina, Inc., Guardant Health, Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Agilent Technologies, Inc., Genome Medical, Inc., and Others.

Report Details

  • Report Code:39718
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:August 2024
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033
  • Download Sample

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert